Medivir to Focus on its Clinical Development and Appoints Uli Hacksell as Acting CEO

STOCKHOLM, Oct 15, 2018 -- (Healthcare Sales & Marketing Network) -- Medivir AB (Nasdaq Stockholm: MVIR) announced today its plans to concentrate its activities on clinical development. As a result, the board has appointed Dr. Uli Hacksell as the company'... Biopharmaceuticals, Oncology, Personnel Medivir, remetinostat, birinapant
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news